HemCon Dental Dressing Receives CE Mark

HemCon Medical Technologies, of Portland, OR, has received clearance to sell its Dental Dressing in Europe, satisfying the international demand that’s been present since the product became available last year in the U.S. Armed with the CE Mark, the company will begin distributing dressings in the U.K.,...

Chembio Teams Up with Pall Corporation

Chembio Diagnostics, of Medford, NY, has signed an R&D deal with Pall Corporation for use of Chembio’s new Dual Path Platform (DPP) immunoassay. The collaboration will involve a two-phase funded feasibility study to determine certain performance characteristics of DPP when used in conjunction with...

New Cerebral-Aneurysm Device Cleared in Europe

ev3, a Plymouth, MN-based endovascular device firm, has received CE Mark approval for a new product that treats cerebral aneurysm. The Axium Detachable Coil System was approved for the endovascular embolization of intracranial aneurysms and other neurovascular abnormalities such as arteriovenous...

Breast-Cancer Detection Firm Seeks Series C Funding

Infrared Sciences, a Stony Brook, NY-based company focused on early breast-cancer detection, is seeking $5 million in fourth-round financing, to further advance its Sentinel BreastScan technology. Unlike mammography, ultrasound or MRI, which detect anatomical features such as a mass, the Sentinel BreastScan...

New England Aesthetic Startups Attract Venture Capital

A number of aesthetic startups from Boston and its surrounding areas may be hitting the scene at precisely the right time. That’s according to the latest edition of “Innovation Economy,” a new Boston Globe column about entrepreneurship, which says that financially able baby boomers and a...

BioForce Nanosciences Backed by NIH Grant

BioForce Nanosciences, a nanotech company based in Ames, IA, has received the second half of a $400,000 grant from the National Institutes of Health (NIH). The funding will be used to develop and test BioForce’s Chip-on-a-Tip technology, a nanobiosensor capable of detecting protein biomarkers from just...

Plexus Biomedical Raises $2 Million

Plexus Biomedical, a small device company based in Oakland, TN, has raised $2 million from individual investors, according to an exclusive report by TechJournal South. The company’s CEO, David Burton, was tight lipped about Plexus’ technology, but research by TechJournal on clinicaltrials.gov...

VC Industry Takes Up Reimbursement with Congress

The National Venture Capital Association (NVCA) is meeting with Congress today to make recommendations for more transparent and expedited reimbursement policies for new medical technologies. The association will be talking with Congress’ House Medical Technology Caucus, about how inefficient...